Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LETROZOLE for Breast cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9,332 adverse event reports in the FDA FAERS database where LETROZOLE was used for Breast cancer.

Most Reported Side Effects for LETROZOLE

Side Effect Reports % Deaths Hosp.
Neutropenia 3,683 11.8% 177 551
Fatigue 3,568 11.5% 440 825
Malignant neoplasm progression 3,445 11.1% 506 517
Nausea 2,894 9.3% 424 1,034
Arthralgia 2,318 7.4% 250 449
Diarrhoea 2,282 7.3% 363 756
Metastases to bone 1,735 5.6% 130 294
Dyspnoea 1,621 5.2% 461 793
Asthenia 1,589 5.1% 364 534
Vomiting 1,560 5.0% 368 758
Breast cancer metastatic 1,540 4.9% 296 293
Alopecia 1,506 4.8% 47 312
Pain 1,454 4.7% 115 446
Anaemia 1,399 4.5% 152 619
Breast cancer 1,393 4.5% 169 228

Other Indications for LETROZOLE

Breast cancer metastatic (6,856) Product used for unknown indication (6,148) Hormone receptor positive her2 negative breast cancer (1,106) Invasive ductal breast carcinoma (771) Breast cancer female (593) Her2 positive breast cancer (568) Breast cancer stage iv (324) Ovarian cancer (297) Metastases to bone (263) Neoplasm malignant (261)

Other Drugs Used for Breast cancer

TRASTUZUMAB (15,522) PALBOCICLIB (13,075) DOCETAXEL (11,735) PACLITAXEL (10,215) CYCLOPHOSPHAMIDE (8,826) PERTUZUMAB (7,532) RIBOCICLIB (6,953) CAPECITABINE (5,767) EPIRUBICIN (5,444) ABEMACICLIB (4,719)

Related Pages

LETROZOLE Full Profile All Breast cancer Drugs LETROZOLE Demographics LETROZOLE Timeline